Skip to main content

Advertisement

SpringerLink
Log in

Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT in vitro and in vivo

  • Published:
Journal of Biosciences Aims and scope Submit manuscript

Abstract

Long non-coding RNAs (lncRNAs) cancer susceptibility candidate 2 (CASC2) has been characterized as a tumor suppressor in glioma. Although CASC2 may predict the prognosis of glioma patients, the role and mechanism of CASC2 in human glioblastoma remain to be fully illuminated. Expression of CASC2 and miR-18a was detected using RT-qPCR. Cell growth was evaluated by MTT assay, colony formation assay, and flow cytometry; metastasis and epithelial-mesenchymal transition (EMT) were determined with transwell assay and Western blot, respectively. The target binding between CASC2 and miR-18a was predicted on Starbase software, and confirmed by luciferase reporter assay and RNA immunoprecipitation. Xenograft experiment measured tumor growth. As a result, CASC2 was downregulated and miR-18a was upregulated in glioblastoma tumor tissues and cells (T98 and A172). Overexpression of CASC2 promoted apoptosis rate and E-cadherin expression, but suppressed cell viability, colony-forming ability, migration, invasion, and expression of N-cadherin and Vimentin in T98 and A172 cells, accompanied with tumor growth inhibition in vivo; whereas, silencing of CASC2 exerted the opposite effect on cell growth, metastasis and EMT of T98 and A172 cells in vitro. However, reintroduction of miR-18a could reverse CASC2 upregulation-mediated suppression on above cell behaviors in vitro. More importantly, miR-18a was a downstream target for CASC2, and was negatively regulated by CASC2. Collectively, this study demonstrated that CASC2 served as tumor suppressor in glioblastoma by inhibiting cell growth, metastasis and EMT both in vitro and in vivo partially via CASC2-miR-18a axis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Cai J, Zuo X, Chen Z, Zhao W, Zhu Y, Zhang Z and Ye X 2018 Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis. Cancer Manag Res. 10 1403–1412

    Article  CAS  Google Scholar 

  • Cruceru ML, Enciu AM, Popa AC, Albulescu R, Neagu M, Tanase CP and Constantinescu SN 2013 Signal transduction molecule patterns indicating potential glioblastoma therapy approaches. Onco Targets Ther. 6 1737–1749

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fox JL, Dews M, Minn AJ and Thomas-Tikhonenko A 2013 Targeting of TGFbeta signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma. RNA 19 177–190

    Article  CAS  Google Scholar 

  • Huang G, Wu X, Li S, Xu X, Zhu H and Chen X 2016 The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer. Sci. Rep. 6 26524

    Article  CAS  Google Scholar 

  • Jiang C, Shen F, Du J, Fang X, Li X, Su J, Wang X, Huang X and Liu Z 2018 Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. Biomed. Pharmacother. 97 844–850

    Article  CAS  Google Scholar 

  • Jiang Y, Zhou J, Zhao J, Hou D, Zhang H, Li L, Zou D, Hu J, Zhang Y, and Jing Z: MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway. EBioMedicine 52 102651, 2020.

    Article  Google Scholar 

  • Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, Lu L, Liu C, Yi JS, Zhang H, Min W, Bennett AM, Gregory RI, Ding Y and Huang Y 2013 The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell. 52 101–112

    Article  CAS  Google Scholar 

  • Khorkova O, Hsiao J and Wahlestedt C 2015 Basic biology and therapeutic implications of lncRNA. Adv. Drug Deliv. Rev. 87 15–24

    Article  CAS  Google Scholar 

  • Komatsu S, Ichikawa D, Takeshita H, Morimura R and Hirajima S 2014 Circulating mir-18a: A sensitive cancer screening biomarker in human cancer. In vivo 28 293–297

    CAS  PubMed  Google Scholar 

  • Lefranc F, Facchini V and Kiss R 2007 Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12 1395–1403

    Article  CAS  Google Scholar 

  • Lefranc F, Rynkowski M, DeWitte O and Kiss R 2009 Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv. Tech. Stand. Neurosurg. 34 3–35

    Article  CAS  Google Scholar 

  • Li Z, Xu C, Ding B, Gao M, Wei X and Ji N 2017 Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101. J. Neurooncol. 134 19–28

    Article  CAS  Google Scholar 

  • Liao Y, Shen L, Zhao H, Liu Q and Fu J 2017 LncRNA CASC2 Interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway. J. Cell Biochem. 118 1889–1899

    Article  CAS  Google Scholar 

  • Liu Q, Yu W, Zhu S, Cheng K, Xu H, Lv Y, Long X, Ma L, Huang J, Sun S and Wang K 2018 Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p. J. Cell Physiol. 234 757–768

    Article  Google Scholar 

  • Meng L, Ma P, Cai R, Guan Q, Wang M and Jin B 2018 Long noncoding RNA ZEB1-AS1 promotes the tumorigenesis of glioma cancer cells by modulating the miR-200c/141-ZEB1 axis. Am. J. Transl. Res. 10 3395–3412

    CAS  PubMed  PubMed Central  Google Scholar 

  • Palmieri G, Paliogiannis P, Sini MC, Manca A, Palomba G, Doneddu V, Tanda F, Pascale MR and Cossu A 2017 Long non-coding RNA CASC2 in human cancer. Crit. Rev. Oncol. Hematol. 111 31–38

    Article  Google Scholar 

  • Quan J, Qu J and Zhou L 2017 MicroRNA-539 inhibits glioma cell proliferation and invasion by targeting DIXDC1. Biomed. Pharmacother. 93 746–753

    Article  CAS  Google Scholar 

  • Song Y, Wang P, Zhao W, Yao Y, Liu X, Ma J, Xue Y and Liu Y 2014 MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin. Exp. Cell Res. 324 54–64

    Article  CAS  Google Scholar 

  • Sun Y, Liu J, Chu L, Yang W, Liu H, Li C and Yang J 2018 Long noncoding RNA SNHG12 facilitates the tumorigenesis of glioma through miR-101–3p/FOXP1 axis. Gene 676 315–321

    Article  CAS  Google Scholar 

  • Vecera M, Sana J, Lipina R, Smrcka M and Slaby O 2018 Long non-coding rnas in gliomas: From molecular pathology to diagnostic biomarkers and therapeutic targets. Int. J. Mol. Sci. 19 2754

    Article  Google Scholar 

  • Wang K, Long B, Zhou LY, Liu F, Zhou QY, Liu CY, Fan YY and Li PF 2014 CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat. Commun. 5 3596

    Article  Google Scholar 

  • Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J and Xue YX 2015 Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal. 27 275–282

    Article  CAS  Google Scholar 

  • Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R, Pu P, Kang C and Han L 2016 A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett. 373 251–259

    Article  CAS  Google Scholar 

  • Wang R, Li Y, Zhu G, Tian B, Zeng W, Yang Y and Li Z 2017 Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/beta-catenin signaling pathway. Neuropsychiatr. Dis. Treat. 13 1805–1813

    Article  CAS  Google Scholar 

  • Wang X, Yan Y, Zhang C, Wei W, Ai X, Pang Y and Bian Y 2018 Upregulation of lncRNA PlncRNA-1 indicates the poor prognosis and promotes glioma progression by activation of Notch signal pathway. Biomed. Pharmacother. 103 216–221

    Article  CAS  Google Scholar 

  • Wei N, Wei H and Zhang H 2018 Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577. Eur. Rev. Med. Pharmacol. Sci. 22 3085–3093

    CAS  PubMed  Google Scholar 

  • Wilusz JE 2016 Long noncoding RNAs: Re-writing dogmas of RNA processing and stability. Biochim. Biophys. Acta 1859 128–138

    Article  CAS  Google Scholar 

  • Wu W, Zhou X, Yu T, Bao Z, Zhi T, Jiang K, Nie E, Wang Y, Zhang J and You Y 2017 The malignancy of miR-18a in human glioblastoma via directly targeting CBX7. Am. J. Cancer Res. 7 64–76

    CAS  PubMed  PubMed Central  Google Scholar 

  • Xu D, Yu J, Gao G, Lu G, Zhang Y and Ma P 2018 LncRNA DANCR functions as a competing endogenous RNA to regulate RAB1A expression by sponging miR-634 in glioma. Biosci. Rep. 38 https://doi.org/10.1042/bsr20171664

    Article  PubMed  PubMed Central  Google Scholar 

  • Yu L, Chen S, Bao H, Zhang W, Liao M, Liang Q and Cheng X 2018 The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics. Onco Targets Ther. 11 4355–4365

    Article  Google Scholar 

  • Yu X and Li Z 2016 Serum microRNAs as potential noninvasive biomarkers for glioma. Tumour Biol. 37 1407–1410

    Article  CAS  Google Scholar 

  • Zhang Y, Qian W, Feng F, Cao Q, Li Y, Hou Y, Zhang L and Fan J 2019 upregulated lncRNA CASC2 may inhibit malignant melanoma development through regulating miR-18a-5p/RUNX1. Oncol. Res. 27 371–377

    Article  Google Scholar 

  • Zhou J, Wang M and Deng D 2018 c-Fos/microRNA-18a feedback loop modulates the tumor growth via HMBOX1 in human gliomas. Biomed. Pharmacother. 107 1705–1711

    Article  CAS  Google Scholar 

  • Zhu ZM, Liu FT and Chen X 2018 Low expression of LncRNA cancer susceptibility candidate 2 and its clinical significance in cancer tissues. Cell Physiol. Biochem. 46 1643–1649

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, The First People’s Hospital of Changde City, Changde, 415000, Hunan, China

    Jun Wang, Chao Qin, Chen Zhong & Yong Wen

  2. Department of Neurology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan, China

    Sha Ke & Bo Liao

Authors
  1. Jun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chao Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chen Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yong Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sha Ke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bo Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bo Liao.

Additional information

Corresponding editor: Tapas Kumar Kundu

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Qin, C., Zhong, C. et al. Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT in vitro and in vivo. J Biosci 45, 107 (2020). https://doi.org/10.1007/s12038-020-00077-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12038-020-00077-8

Keywords

Search

Navigation